Three Declining Giants
Intel, Walgreens, and Starbucks are useful case studies precisely because they are household names. All three have lost significant market value, cycled through leadership, and struggled to respond to shifting competitive dynamics. Their visibility makes them accessible examples of a broader pattern: what happens when mature businesses lose their competitive position.
Intel: A Semiconductor Leader Off-Pace
Intel's problems are structural, not cyclical. Revenue growth has slowed, margins have compressed, and competitive positioning relative to TSMC (in process technology) and Nvidia (in AI accelerators) has deteriorated. The company has invested heavily in fabrication capacity and AI capabilities, but investors remain skeptical that capital spending alone can close the gap.
From a valuation standpoint, Intel illustrates the critical error of extrapolating mature-stage margins into perpetuity. Companies that have lost technology leadership frequently cannot recover their prior margin structure even if revenue stabilizes.
Walgreens: Pharmacy Retail Under Pressure
Walgreens' challenges hit the core of its business: prescription margins are eroding, retail store traffic is declining, and competitors — particularly CVS with its integrated payer-provider model — have built structural advantages. Acquisition-driven growth strategies have repeatedly failed to reverse the financial deterioration.
The Walgreens lesson is about reinvestment rate in decline. Continued capital deployment into a deteriorating business compounds the problem rather than solving it.
Starbucks: Growth Questions at a Stable Business
Starbucks is the most interesting of the three because it remains profitable and retains a strong brand. The issues are specifically about growth trajectory: operational headwinds in China, cost pressures on the core US business, and softening comparable store sales. Investors have repriced the company's growth expectations downward, which is a different problem than core business decline.
A Framework for Aging Companies
Damodaran identifies three strategic pathways companies take when their growth trajectory inflects:
- Destructive: Denial, desperation, and survival-focused moves. Typically involves doubling down on the failing strategy, making risky acquisitions, or taking on leverage to buy back shares at the wrong price.
- Contingent: Me-too responses. The company mimics a competitor's strategy without genuine conviction, often producing neither differentiation nor focus.
- Constructive: Acceptance, renewal, and in some cases rebirth. The rare but achievable path involves honestly assessing competitive position, resizing the business, and reinvesting only where returns on capital actually exceed cost of capital.
Implications for Valuation
When valuing a company suspected to be in decline:
- Resist linear extrapolation of historical growth into terminal value
- Stress-test margin assumptions against peers that have lost similar competitive positions
- Measure return on incremental invested capital separately from overall ROIC — the former often reveals decline earlier
- Value announced turnaround strategies with probability-weighted scenarios rather than point estimates
The Endgame
Damodaran's broader argument is cultural: business media and markets celebrate growth CEOs almost exclusively. The skill of managing "orderly shrinkage of declining companies" is equally valuable and arguably scarcer. Recognizing that decline is a natural life-cycle stage, and that genuine value can be created by managing it well, is the right framing for practitioners and operators alike.
Bottom Line
Intel, Walgreens, and Starbucks each face different versions of the aging problem. The response that creates value across all three is honest acknowledgment of competitive position, disciplined reinvestment, and realistic growth expectations. Denial and me-too strategies destroy more value than they preserve.